These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 7308718)

  • 21. Time of optimal gallbladder opacification with bilopaque (tyropanoate sodium).
    Oliphant M; Whalen JP; Evans JA
    Radiology; 1974 Sep; 112(3):531-2. PubMed ID: 4843281
    [No Abstract]   [Full Text] [Related]  

  • 22. The present status of imaging of the gallbladder.
    Berk RN; Leopold GR
    Invest Radiol; 1978; 13(6):477-89. PubMed ID: 383643
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Imaging procedures prior to the extracorporeal shockwave lithotripsy of gallstones].
    Schneider HT; Ell C; Benninger J; Theobaldy S; Friedel N; Rödl W; Heyder N; Hahn EG
    Dtsch Med Wochenschr; 1991 Jan; 116(4):128-33. PubMed ID: 1988274
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The influence of fasting on opacification of the gallbladder during oral cholecystography using two consecutive doses in a canine model.
    Thoeni RF; Moss AA; Stoughton JA
    Invest Radiol; 1979; 14(3):228-32. PubMed ID: 468495
    [TBL] [Abstract][Full Text] [Related]  

  • 25. TYROPANOATE SODIUM. A NEW ORAL CHOLECYSTOGRAPHIC MEDIUM.
    DAVIS JJ
    Rocky Mt Med J; 1964 Apr; 61():35-9. PubMed ID: 14137928
    [No Abstract]   [Full Text] [Related]  

  • 26. Effects of three-day oral cholecystography on serum iodothyronines and TSH concentrations: comparison of the effects among some cholecystographic agents and the effects of iopanoic acid on the pituitary-thyroid axis.
    Suzuki H; Kadena N; Takeuchi K; Nakagawa S
    Acta Endocrinol (Copenh); 1979 Nov; 92(3):477-88. PubMed ID: 517049
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Radiographic appearance of the nonabsorbed (unconjugated) and conjugated sodium tyropanoate (Bilopaque) in the bowel.
    Muhletaler CA; Gerlock AJ; Amberg JR; Avant GR
    Invest Radiol; 1982; 17(5):506-9. PubMed ID: 7141832
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ALTERED CONCEPTS OF THE MECHANISM OF NONVISUALIZATION OF THE GALLBLADDER.
    BERK RN; LASSER EC
    Radiology; 1964 Feb; 82():296-302. PubMed ID: 14115313
    [No Abstract]   [Full Text] [Related]  

  • 29. [The absorption of cholecystographic contrast media, following intraduodenal application; reasons for improved absorption due to sodium bicarbonate (author's transl)].
    Hofmann EF
    Rofo; 1975 Dec; 123(6):522-5. PubMed ID: 129405
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Helical CT cholangiography with oral cholecystographic contrast material.
    Chopra S; Chintapalli KN; Ramakrishna K; Rhim H; Dodd GD
    Radiology; 2000 Feb; 214(2):596-601. PubMed ID: 10671618
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Results obtained with cholebrine after low-fat and high-fat preparation.
    Thijn CJ
    Radiol Clin Biol; 1971; 40(1):47-9. PubMed ID: 5547379
    [No Abstract]   [Full Text] [Related]  

  • 32. Clinical comparison of two contrast agents for oral cholecystography: radiologic efficacy and drug safety of iopanoic acid and iopronic acid.
    Hedlund L; Putman CE; Burrell M
    Yale J Biol Med; 1979; 52(3):257-62. PubMed ID: 380184
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The combined use of oral cholecystopaque media and iodipamide.
    Goergen T; Goldberger LE; Berk RN
    Radiology; 1974 Jun; 111(3):543-8. PubMed ID: 4828985
    [No Abstract]   [Full Text] [Related]  

  • 34. Clinical comparison of tyropanoate sodium, ipodate sodium, and iopanoic acid.
    Russell JG; Frederick PR
    Radiology; 1974 Sep; 112(3):519-23. PubMed ID: 4843279
    [No Abstract]   [Full Text] [Related]  

  • 35. Opacification of the gallbladder following intravenous contrast injection in patients with normal renal function.
    Ford KK; Wysong B; Thompson WM
    Urol Radiol; 1983; 5(4):251-2. PubMed ID: 6659205
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oral cholecystography: osmotic activity of iopanoic glucuronide in bile.
    Mudge GH; Cooke WJ
    Johns Hopkins Med J; 1975 Aug; 137(2):65-8. PubMed ID: 1160206
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oral cholecystographic contrast media--a comparative study.
    Roberts GM; Jones MR
    J Clin Hosp Pharm; 1984 Sep; 9(3):225-30. PubMed ID: 6238047
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [ON THE EARLY DEMONSTRATION OF THE GALLBLADDER AND THE BILE DUCTS AFTER ORAL AND RECTAL APPLICATION OF TRIIODINATED CONTRAST MEDIUM].
    ANDERSCH H; RICHTER K
    Dtsch Gesundheitsw; 1964 Apr; 19():638-9. PubMed ID: 14204589
    [No Abstract]   [Full Text] [Related]  

  • 39. A CLINICAL TRIAL OF ORAL CHOLECYSTOGRAPHIC MEDIA: TELEPAQUE, BILOPTIN, OSBIL TABLETS AND OSBIL CAPSULES.
    HEALEY T; GRAINGER RG
    Br J Radiol; 1965 Jan; 38():57-62. PubMed ID: 14236022
    [No Abstract]   [Full Text] [Related]  

  • 40. Oral cholecystography with iopanoic acid.
    Berk RN; Loeb PM; Goldberger LE; Sokoloff J
    N Engl J Med; 1974 Jan; 290(4):204-10. PubMed ID: 4587633
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.